2023 Form 5500 filing — Sangamo Therapeutics Inc. 401(K) Profit Sharing Plan And Trust

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241015145505NAL0030054209001) for Sangamo Therapeutics Inc. 401(K) Profit Sharing Plan And Trust, reported by Sangamo Therapeutics, Inc. under EIN 68-0359556 and plan number 001. It reports 551 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241015145505NAL0030054209001
Filing year
2023
Form type
2
Plan sponsor
Sangamo Therapeutics, Inc.
EIN
68-0359556
Plan number
001
Location
Richmond, CA
Participants
551
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$55,271,426
Total liabilities (EOY)
$0
Net assets (EOY)
$55,271,426
Employer contributions
$1,751,825
Participant contributions
$6,791,016
Total income / additions
$17,895,514
Benefits paid
$6,148,478
Administrative expenses
$23,879
Total expenses
$6,186,688
Net increase / (decrease)
$11,708,826
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Resources Investment Advisors LLCADVISOR$21,324not reported in the loaded dataset
Fidelity Investments InstitutionalRECORDKEEPER$2,555$0

Related Form 5500 pages